OUT OF MIND
Would you like to react to this message? Create an account in a few clicks or log in to continue.
Latest topics
» Enormous sinkhole swallows up the ground in Chile
BYE-BYE VAX: Merck Unveils COVID Pill that Cuts Hospitalizations in Half EmptyToday at 9:42 am by PurpleSkyz

» Joe Biden Unleashes Machine Gun-Toting Agent on Trump’s Mar-a-Lago Residence
BYE-BYE VAX: Merck Unveils COVID Pill that Cuts Hospitalizations in Half EmptyToday at 9:24 am by PurpleSkyz

» Aussie Doctor Risks Medical License to Tell the Truth About COVID Vaccine Injuries and Deaths
BYE-BYE VAX: Merck Unveils COVID Pill that Cuts Hospitalizations in Half EmptyToday at 9:12 am by PurpleSkyz

» Since covid “vaccines” were unleashed, athlete deaths are up 1700%
BYE-BYE VAX: Merck Unveils COVID Pill that Cuts Hospitalizations in Half EmptyYesterday at 10:05 am by PurpleSkyz

»  Cancer Explosion: Pathologist Reports on Rise of Aggressive Cancers Since mRNA Shots
BYE-BYE VAX: Merck Unveils COVID Pill that Cuts Hospitalizations in Half EmptyYesterday at 9:59 am by PurpleSkyz

» ‘Revolution Has Begun’: 75,000 Brits To Stop Paying Power Bills Amid Inflation Storm
BYE-BYE VAX: Merck Unveils COVID Pill that Cuts Hospitalizations in Half EmptyYesterday at 9:41 am by PurpleSkyz

» “Before You Inject Your Child” – Dr. Robert Malone
BYE-BYE VAX: Merck Unveils COVID Pill that Cuts Hospitalizations in Half EmptyYesterday at 9:34 am by PurpleSkyz

» Unleashed by Democrats, the IRS ‘beast’ is coming for all with incomes under $200K a year
BYE-BYE VAX: Merck Unveils COVID Pill that Cuts Hospitalizations in Half EmptyYesterday at 9:17 am by PurpleSkyz

» 24-Year-Old Irish Athlete Dillon Quirke Dies Unexpectedly After Collapsing Mid-Game
BYE-BYE VAX: Merck Unveils COVID Pill that Cuts Hospitalizations in Half EmptySun Aug 07, 2022 6:48 pm by PurpleSkyz

» Ou Yang Li-hsing Found Dead in Hotel Room…After Pelosi’s Visit…Heart Attack?
BYE-BYE VAX: Merck Unveils COVID Pill that Cuts Hospitalizations in Half EmptySun Aug 07, 2022 6:44 pm by PurpleSkyz

» Find Out if You’re Eligible for Part of the $90M Facebook Data Tracking Settlement
BYE-BYE VAX: Merck Unveils COVID Pill that Cuts Hospitalizations in Half EmptySun Aug 07, 2022 10:03 am by PurpleSkyz

» The “Unvaccinated” Question (Revisited)
BYE-BYE VAX: Merck Unveils COVID Pill that Cuts Hospitalizations in Half EmptySun Aug 07, 2022 8:48 am by PurpleSkyz

» These people are nuts: Reuters Links Deadly DC Lightning Strike To Global Warming
BYE-BYE VAX: Merck Unveils COVID Pill that Cuts Hospitalizations in Half EmptySun Aug 07, 2022 8:44 am by PurpleSkyz

» Thousands of Jabbed Teenage Girls Are Developing Tics, Doctors Baffled
BYE-BYE VAX: Merck Unveils COVID Pill that Cuts Hospitalizations in Half EmptySun Aug 07, 2022 8:34 am by PurpleSkyz

» EUDRA Stats thru July 30th 2022
BYE-BYE VAX: Merck Unveils COVID Pill that Cuts Hospitalizations in Half EmptySun Aug 07, 2022 8:21 am by PurpleSkyz

» US Declares Monkeypox Public Health Emergency – Big Pharma Ready for Windfall Profits, Again
BYE-BYE VAX: Merck Unveils COVID Pill that Cuts Hospitalizations in Half EmptySun Aug 07, 2022 7:56 am by PurpleSkyz

» Good Samaritans Fined, Threatened with Arrest for Pulling Government Litter Out of a River
BYE-BYE VAX: Merck Unveils COVID Pill that Cuts Hospitalizations in Half EmptySun Aug 07, 2022 7:52 am by PurpleSkyz

» MRNA 'VACCINE' GENOCIDE 2021-2022: TESTIMONIES FROM THE VICTIMS AND MEDICAL STAFF
BYE-BYE VAX: Merck Unveils COVID Pill that Cuts Hospitalizations in Half EmptyWed Aug 03, 2022 10:17 am by PurpleSkyz

» Mysterious metallic orb containing a secret code inside falls on Veracruz, Mexico
BYE-BYE VAX: Merck Unveils COVID Pill that Cuts Hospitalizations in Half EmptyWed Aug 03, 2022 10:10 am by PurpleSkyz

» 10,000% Increase in Cancers Following COVID-19 Vaccines as Doctors and Scientists Worldwide Sound the Alarm
BYE-BYE VAX: Merck Unveils COVID Pill that Cuts Hospitalizations in Half EmptyWed Aug 03, 2022 9:55 am by PurpleSkyz

» Good People Doing Good Things – Dr. Sanduk Ruit & Dr. Geoffrey Tabin
BYE-BYE VAX: Merck Unveils COVID Pill that Cuts Hospitalizations in Half EmptyWed Aug 03, 2022 9:48 am by PurpleSkyz

» UK Government admits 19 million Brits remain Unvaccinated & 30 million Brits have refused the COVID Booster Jab
BYE-BYE VAX: Merck Unveils COVID Pill that Cuts Hospitalizations in Half EmptyWed Aug 03, 2022 9:38 am by PurpleSkyz

You are not connected. Please login or register

OUT OF MIND » BREAKING NEWS & HOT TOPICS » THE GREAT DIE OFF » BYE-BYE VAX: Merck Unveils COVID Pill that Cuts Hospitalizations in Half

BYE-BYE VAX: Merck Unveils COVID Pill that Cuts Hospitalizations in Half

Go down  Message [Page 1 of 1]

PurpleSkyz

PurpleSkyz
Admin

BYE-BYE VAX: Merck Unveils COVID Pill that Cuts Hospitalizations in Half
Date: October 1, 2021Author: Nwo Report  0 Comments  
“It exceeded what I thought the drug might be able to do in this clinical trial. When you see a 50% reduction in hospitalization or death that’s a substantial clinical impact…”


BYE-BYE VAX: Merck Unveils COVID Pill that Cuts Hospitalizations in Half Image-5


Source: AP
(Headline USA) Merck & Co. said Friday that its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus and that it would soon ask health officials in the U.S. and around the world to authorize its use.
If cleared, Merck’s drug would be the first pill shown to treat COVID-19, a potentially major advance in efforts to fight the pandemic. All COVID-19 therapies now authorized in the U.S. require an IV or injection.
Merck and its partner Ridgeback Biotherapeutics said early results showed patients who received the drug, called molnupiravir, within five days of COVID-19 symptoms had about half the rate of hospitalization and death as patients who received a dummy pill. The study tracked 775 adults with mild-to-moderate COVID-19 who were considered higher risk for severe disease due to health problems such as obesity, diabetes or heart disease.
Among patients taking molnupiravir, 7.3% were either hospitalized or died at the end of 30 days, compared with 14.1% of those getting the dummy pill. There were no deaths in the drug group after that time period compared with eight deaths in the placebo group, according to Merck. The results were released by the company and have not been peer reviewed. Merck said it plans to present them at a future medical meeting.
An independent group of medical experts monitoring the trial recommended stopping it early because the interim results were so strong. Company executives said they are in discussions with the Food and Drug Administration and plan submit the data for review in coming days.
“It exceeded what I thought the drug might be able to do in this clinical trial,” said Dr. Dean Li, vice president of Merck research. “When you see a 50% reduction in hospitalization or death that’s a substantial clinical impact.”
Side effects were reported by both groups in the Merck trial, but they were slightly more common among the group that received a dummy pill. The company did not specify the problems.
Earlier study results showed the drug did not benefit patients who were already hospitalized with severe disease.
The U.S. has approved one antiviral drug, remdesivir, specifically for COVID-19, and allowed emergency use of three antibody therapies that help the immune system fight the virus. But all the drugs have to given by IV or injection at hospitals or medical clinics, and supplies have been stretched by the latest surge of the delta variant.
Health experts including the COVID czar Anthony Fauci have long called for a convenient pill that patients could take when COVID-19 symptoms first appear, much the way the decades-old flu medication Tamiflu helps fight influenza. Such medications are seen as key to controlling future waves of infection and reducing the impact of the pandemic.
Merck’s pill works by interfering with an enzyme the coronavirus uses to copy its genetic code and reproduce itself. It has shown similar activity against other viruses.
The U.S. government has committed to purchase 1.7 million doses of the drug if it is authorized by the FDA. Merck has said it can produce 10 million doses by the end of the year and has contracts with governments worldwide. The company has not announced prices.
Several other companies, including Pfizer and Roche, are studying similar drugs that could report results in the coming weeks and months.
Merck had planned to enroll more than 1,500 patients in its late-stage trial before the independent board stopped it early. The results reported Friday included patients enrolled across Latin America, Europe and Africa. Executives estimated about 10% of patients studied were from the U.S.

https://nworeport.me/2021/10/01/bye-bye-vax-merck-unveils-covid-pill-that-cuts-hospitalizations-in-half/
Thanks to: https://nworeport.me



  

Back to top  Message [Page 1 of 1]

Permissions in this forum:
You cannot reply to topics in this forum